Industry News
Precision Neuroscience signs Cleveland Clinic Abu Dhabi as its first research site outside the US
Precision Neuroscience signed a two-year memorandum of understanding with Cleveland Clinic Abu Dhabi on 21 October 2026, with the support of the Department of Health Abu Dhabi, to evaluate its Layer 7 cortical interface in collaborative clinical research. It is the company's first clinical research site outside the United States. The same hospital hosts Neuralink's UAE-PRIME trial, and Abu Dhabi's Mubadala Capital took part in Precision's $250 million Series D.